American Journal of Kidney Diseases
Volume 52, Issue 6, Supplement 1 , Pages S5-S13, December 2008

The Controversy Surrounding Hemoglobin and Erythropoiesis-Stimulating Agents: What Should We Do Now?

  • Ajay K. Singh, MBBS, FRCP

      Affiliations

    • Corresponding Author InformationAddress correspondence to Ajay K. Singh, MBBS, FRCP, Renal Division, Brigham and Women's Hospital, Boston, MA

Renal Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This article was published as part of a supplement sponsored by an educational grant from Watson Pharmaceuticals.

PII: S0272-6386(08)01349-8

doi:10.1053/j.ajkd.2008.09.010

American Journal of Kidney Diseases
Volume 52, Issue 6, Supplement 1 , Pages S5-S13, December 2008

Article Tools

* Image Usage & Resolution